On 25th February 2021, Icon Group opened its fourth Icon Cancer Centre in China at Fenghuang Hospital in Fengcheng. The state-of-the-art centre marks a milestone in the Group’s maturity in the region and another step towards providing the best possible care closer to home for millions of Chinese across the region.
The new Icon Cancer Centre in Fengcheng in China’s northeast, Liaoning province is equipped with a Varian Medical Systems TrueBeam linear accelerator, which has the capability to deliver the latest in radiation therapy techniques, including HyperArc technology – advanced radiation therapy delivering precision stereotactic radiosurgery for multiple brain metastases. The centre will be the first in the region to offer this cutting-edge technology helping to advance healthcare in the community and improve quality of life and outcomes for patients living with advanced secondary cancers.
Alongside the latest in radiation therapy, the centre will also include a PET/CT providing a comprehensive approach to cancer care including screening, diagnosis and imaging. This PET/CT will service patients within Fenghuang hospital and surrounding regions, providing convenience and continuity of care. The addition of a PET/CT will have significant clinical benefits for early cancer detection, increased clarity of imaging for management and monitoring of cancers, as well as carrying out diagnostic procedures for many other conditions and disorders.
“Our Fengcheng centre is the group’s first step into PET/CT services and marks a logical move forward in our ability to provide continuity of care for patients within the one location,” said Icon Group CEO, Mark Middleton.
“Despite the challenges of COVID-19 we have continued to seek opportunities to help as many people as we can. In the past 18 months we have worked closely with our esteemed partners across China to be able to deliver world-class cancer centres for the benefit of cancer patients.”